Armis Biopharma, Inc. of FORT COLLINS, CO, a company, filed a Form D amendment with the SEC on 2022-09-15. The offering totals $10.0M, of which $7.3M was reported sold. Industry: Other Health Care.
Showing 25 of 33 people.
| Name | Role | Location |
|---|---|---|
| Ed Neas, Ph.D. | Director | Fort Collins, CO |
| William Nelson, MD. Ph.D. | Director | Fort Collins, CO |
| Christopher Ruud | Director | Fort Collins, CO |
| Ted Ziemann | Director | Fort Collins, CO |
| Christopher Ruud | Executive Officer | Fort Collins, CO |
| Ted Ziemann | Executive Officer | Fort Collins, CO |
| Michael Handley | Director | Fremont, CA |
| Michael Handley | Executive Officer | Fremont, CA |
| William Nelson | Director | Las Vegas, NV |
| Theodore Ziemann | Director | Fort Collins, CO |
| Alan Ruud | Director | Fort Collins, CO |
| Steve Coder | Director | Fort Collins, CO |
| Steve Coder | Executive Officer | Fort Collins, CO |
| Michael Voss | Director | Austin, TX |
| Michael Voss | Executive Officer | Austin, TX |
| William Nelson, MD, Ph.D. | Director | Fort Collins, CO |
| Michael Litwack | Director | Fort Collins, CO |
| Alan Smith, Ph.D. | Director | Fort Collins, CO |
| Christopher Rudd | Director | Fort Collins, CO |
| Alan Smith | Director | Rydal, PA |
| Stephen Coder | Director | Fort Collins, CT |
| Robert Kali | Executive Officer | Fort Collins, CO |
| Ed Neas | Director | Fort Collins, CO |
| Ed Neas | Executive Officer | Fort Collins, CO |
| Dennis Templar | Director | Fort Collins, CO |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-07-10 | D | $3.0M | $1.0M |
| 2022-02-15 | D | $8.0M | $5.3M |
| 2018-09-25 | D | $10.0M | $1.8M |
| 2017-11-17 | D | $30.0M | $125K |
| 2017-11-17 | D/A | $14.0M | $2.7M |
| 2017-05-12 | D/A | $14.0M | $2.7M |
| 2017-02-09 | D/A | $14.0M | — |
| 2017-01-27 | D | $14.0M | — |
| 2016-06-01 | D/A | $5.8M | $3.3M |
| 2016-03-10 | D | $5.8M | $758K |
| 2016-02-26 | D | $1.7M | $1.7M |
| 2014-04-17 | D/A | $3.2M | $3.2M |
| 2014-04-14 | D | $2.5M | $2.5M |